This inventor holds 124 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Renal Neuromodulation (CPC class A61B18-1492). Top assignees: Medtronic Ardian Luxembourg S.a.r.l., The Foundry, Inc., Twelve, Inc.. Active years: 1996-2026.
Inventors with similar research interests:
Location History:
- San Francisco, CA (US) (1996 - 2001)
- Mountain View, CA (US) (2007 - 2023)
Company Filing History:
44 out of 236 
15 out of 57 
14 out of 76 
Years Active: 1996-2026
Areas of Expertise:
Mark Deem, a highly acclaimed inventor and patent holder, is a resident of Mountain View, CA, in the United States. Deem has amassed a total of 244 patents and is still going strong with groundbreaking inventions. His recent patents on drug delivery methods and structures are nothing short of exceptional.
Deem's latest invention relates to an implant that is meant to be inserted into a punctum of a patient's nasolacrimal system. The implant consists of a body with a distal end, a proximal end, and an axis in between. The body has a therapeutic agent included within an agent matrix drug core, and it is then exposed to tear fluid to effect an effective therapeutic agent release into the tear fluid over time. The implant has a sheath that inhibits the release of the agent away from the proximal end, and its outer surface enhances engagement with luminal wall tissues to prevent expulsion. Moreover, the agent matrix is made up of non-bioabsorbable polymer, such as silicone, in a non-homogenous blend with the agent.
Furthermore, Deem has also created systems, apparatuses, and methods for treating tissue and controlling stenosis. He has built treatment systems that are capable of delivering a coolable ablation assembly that ablates only targeted tissue without damaging non-targeted tissue. Such high precision assures that only nerve tissue will be temporarily or permanently damaged to reduce the nervous system's input. The system, delivery devices, and methods can treat tissue and manage scarring and stenosis.
Deem has worked with several companies, including Mati Therapeutics Inc. and Nuvaira, Inc. He has worked closely with some of his coworkers, including Hanson S. Gifford, III, and Douglas S. Sutton. It is clear that Deem has continually pursued newer, better ways of innovating in the medical field, which explains why he has such a vast number of patents to his name.
In the world of patents and inventions, Mark Deem's name is synonymous with excellence. The sheer number of his patents and the strides he has made in medical innovations is a testament to his skill and expertise. His cutting-edge inventions and dedication to the field will continue to inspire and shape the next generation of inventors.